Warning: The NCBI web site requires JavaScript to function. more...
Atomoxetine treatment and ADHD-related difficulties as assessed by adolescent patients, their parents and physicians.
Dittmann RW, Wehmeier PM, Schacht A, Minarzyk A, Lehmann M, Sevecke K, Lehmkuhl G.
Child Adolesc Psychiatry Ment Health. 2009 Aug 24;3(1):21.
Related citations
Effectiveness of atomoxetine and quality of life in children with attention-deficit/hyperactivity disorder as perceived by patients, parents, and physicians in an open-label study.
Wehmeier PM, Dittmann RW, Schacht A, Minarzyk A, Lehmann M, Sevecke K, Lehmkuhl G.
J Child Adolesc Psychopharmacol. 2007 Dec;17(6):813-30.
Minor differences in ADHD-related difficulties between boys and girls treated with atomoxetine for attention-deficit/hyperactivity disorder.
Wehmeier PM, Schacht A, Dittmann RW, Banaschewski T.
Atten Defic Hyperact Disord. 2010 Jun;2(2):73-85. Epub 2010 Mar 30.
Global impression of perceived difficulties in children and adolescents with attention-deficit/hyperactivity disorder: reliability and validity of a new instrument assessing perceived difficulties from a patient, parent and physician perspective over the day.
Wehmeier PM, Schacht A, Dittmann RW, Döpfner M.
Child Adolesc Psychiatry Ment Health. 2008 May 28;2(1):10.
Morning and evening behavior in children and adolescents treated with atomoxetine once daily for attention-deficit/hyperactivity disorder (ADHD): findings from two 24-week, open-label studies.
Wehmeier PM, Dittmann RW, Schacht A, Helsberg K, Lehmkuhl G.
Child Adolesc Psychiatry Ment Health. 2009 Feb 9;3(1):5.
Effects of atomoxetine on attention-deficit/hyperactivity disorder in clinical pediatric treatment settings: a naturalistic study.
Bakken RJ, Paczkowski M, Kramer HP, Axelson AA, Williams DW, Malcolm SK, Sumner CR, Kelsey DK.
Curr Med Res Opin. 2008 Feb;24(2):449-60.
[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].
Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.
Encephale. 2005 May-Jun;31(3):337-48. Review. French.
Evaluation of atomoxetine for first-line treatment of newly diagnosed, treatment-naïve children and adolescents with attention deficit/hyperactivity disorder.
Montoya A, Hervas A, Cardo E, Artigas J, Mardomingo MJ, Alda JA, Gastaminza X, García-Polavieja MJ, Gilaberte I, Escobar R.
Curr Med Res Opin. 2009 Nov;25(11):2745-54.
Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
Clin Ther. 2006 Feb;28(2):266-79.
A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD).
Prasad S, Harpin V, Poole L, Zeitlin H, Jamdar S, Puvanendran K; SUNBEAM Study Group.
Curr Med Res Opin. 2007 Feb;23(2):379-94.
Efficacy and safety of atomoxetine as add-on to psychoeducation in the treatment of attention deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in stimulant-naïve Swedish children and adolescents.
Svanborg P, Thernlund G, Gustafsson PA, Hägglöf B, Poole L, Kadesjö B.
Eur Child Adolesc Psychiatry. 2009 Apr;18(4):240-9. Epub 2009 Jan 20.
Outcomes of OROS methylphenidate compared with atomoxetine in children with ADHD: a multicenter, randomized prospective study.
Kemner JE, Starr HL, Ciccone PE, Hooper-Wood CG, Crockett RS.
Adv Ther. 2005 Sep-Oct;22(5):498-512.
Acute atomoxetine treatment of younger and older children with ADHD: a meta-analysis of tolerability and efficacy.
Kratochvil CJ, Milton DR, Vaughan BS, Greenhill LL.
Child Adolesc Psychiatry Ment Health. 2008 Sep 15;2(1):25.
[Atomoxetine (Strattera), an alternative in the treatment of attention-deficit/hyperactivity disorder (ADHD) in children].
Gaillez C, Sorbara F, Perrin E.
Encephale. 2007 Sep;33(4 Pt 1):621-8. French.
Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.
Biederman J, Swanson JM, Wigal SB, Kratochvil CJ, Boellner SW, Earl CQ, Jiang J, Greenhill L.
Pediatrics. 2005 Dec;116(6):e777-84.
Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
Dell'Agnello G, Maschietto D, Bravaccio C, Calamoneri F, Masi G, Curatolo P, Besana D, Mancini F, Rossi A, Poole L, Escobar R, Zuddas A; LYCY Study Group.
Eur Neuropsychopharmacol. 2009 Nov;19(11):822-34. Epub 2009 Aug 28.
Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.
Clin Ther. 2007 Jun;29(6):1168-77.
Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial.
Kelsey DK, Sumner CR, Casat CD, Coury DL, Quintana H, Saylor KE, Sutton VK, Gonzales J, Malcolm SK, Schuh KJ, Allen AJ.
Pediatrics. 2004 Jul;114(1):e1-8.
Modafinil in children and adolescents with attention-deficit/hyperactivity disorder: a preliminary 8-week, open-label study.
Boellner SW, Earl CQ, Arora S.
Curr Med Res Opin. 2006 Dec;22(12):2457-65.
A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder.
Biederman J, Wigal SB, Spencer TJ, McGough JJ, Mays DA.
Clin Ther. 2006 Feb;28(2):280-93.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on